AFM
ETTX

Anson Funds Management’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Anson Funds Management’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-92,626
Closed -$229K – 344
2020
Q4 		$229K Buy
+92,626
New +$182K 0.05% 151

Other funds holding ETTX

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Anson Funds Management's ETTX Position: Q1 2021 in Review

Anson Funds Management sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q1 2021, closing a stake of 92,626 shares — an estimated $229K sold.

Anson Funds Management first reported a position in ETTX in Q4 2020 and held it in 1 quarter. The position peaked at $229K in Q4 2020. 25 funds tracked by Wall St. Rank hold ETTX as of Q1 2021.

  • Anson Funds Management reported no remaining Entasis Therapeutics Holdings Inc. position as of Q1 2021 after selling out during the quarter.
  • Anson Funds Management sold 92,626 Entasis Therapeutics Holdings Inc. shares in Q1 2021, an estimated $229K.
  • Anson Funds Management first reported a position in Entasis Therapeutics Holdings Inc. in Q4 2020 and held it in 1 quarter.
  • Anson Funds Management's Entasis Therapeutics Holdings Inc. position peaked at $229K in Q4 2020.
  • 25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q1 2021.

Based on Anson Funds Management's 13F filing for Q1 2021, filed 14 May 2021.